image
Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 6.965
2.58 %
$ 109 M
Market Cap
-0.52
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one AMWL stock under the worst case scenario is HIDDEN Compared to the current market price of 6.96 USD, American Well Corporation is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one AMWL stock under the base case scenario is HIDDEN Compared to the current market price of 6.96 USD, American Well Corporation is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one AMWL stock under the best case scenario is HIDDEN Compared to the current market price of 6.96 USD, American Well Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart AMWL

image
$13.0$13.0$12.0$12.0$11.0$11.0$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.0$6.0$6.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
254 M REVENUE
-1.81%
-218 M OPERATING INCOME
68.57%
-208 M NET INCOME
100.00%
-127 M OPERATING CASH FLOW
14.16%
-18.7 M INVESTING CASH FLOW
2.69%
1.38 M FINANCING CASH FLOW
-35.68%
71 M REVENUE
16.32%
-42.8 M OPERATING INCOME
9.74%
-44.6 M NET INCOME
-1.20%
-13.4 M OPERATING CASH FLOW
58.47%
-4.13 M INVESTING CASH FLOW
12.72%
-2 K FINANCING CASH FLOW
-0.47%
Balance Sheet American Well Corporation
image
Current Assets 317 M
Cash & Short-Term Investments 228 M
Receivables 71.9 M
Other Current Assets 16.8 M
Non-Current Assets 119 M
Long-Term Investments 1.5 M
PP&E 7.58 M
Other Non-Current Assets 110 M
52.37 %16.49 %3.85 %25.21 %Total Assets$436.0m
Current Liabilities 111 M
Accounts Payable 5.02 M
Short-Term Debt 3.69 M
Other Current Liabilities 103 M
Non-Current Liabilities 8.46 M
Long-Term Debt 4.51 M
Other Non-Current Liabilities 3.95 M
4.19 %3.08 %85.66 %3.77 %3.30 %Total Liabilities$119.7m
EFFICIENCY
Earnings Waterfall American Well Corporation
image
Revenue 254 M
Cost Of Revenue 155 M
Gross Profit 99 M
Operating Expenses 316 M
Operating Income -218 M
Other Expenses -9.39 M
Net Income -208 M
300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)254m(155m)99m(316m)(218m)9m(208m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
38.90% GROSS MARGIN
38.90%
-85.52% OPERATING MARGIN
-85.52%
-81.83% NET MARGIN
-81.83%
-68.29% ROE
-68.29%
-47.74% ROA
-47.74%
-67.12% ROIC
-67.12%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis American Well Corporation
image
00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)20192019202020202021202120222022202320232024202420252025
Net Income -208 M
Depreciation & Amortization 33 M
Capital Expenditures 0
Stock-Based Compensation 0
Change in Working Capital 0
Others -127 M
Free Cash Flow -127 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets American Well Corporation
image
Wall Street analysts predict an average 1-year price target for AMWL of $7.2 , with forecasts ranging from a low of $5 to a high of $10 .
AMWL Lowest Price Target Wall Street Target
5 USD -28.21%
AMWL Average Price Target Wall Street Target
7.2 USD 3.37%
AMWL Highest Price Target Wall Street Target
10 USD 43.58%
Price
Max Price Target
Min Price Target
Average Price Target
13131212111110109988776655Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 13
6. Ownership
Insider Ownership American Well Corporation
image
Sold
0-3 MONTHS
54.9 K USD 2
3-6 MONTHS
593 K USD 6
6-9 MONTHS
207 K USD 6
9-12 MONTHS
198 K USD 7
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Amwell® to report first quarter 2025 operating results BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. globenewswire.com - 2 weeks ago
Amwell makes inducement grant BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan Zamansky. The grant was offered as material inducement to Zamansky's employment as Amwell's chief product and technology officer. globenewswire.com - 1 month ago
Amwell announces innovation leader as chief product and technology officer BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company's new chief product and technology officer, effective today. Zamansky will lead the company's product and R&D organizations. globenewswire.com - 1 month ago
Amwell® makes grants to new employees under inducement plan BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its Class A common stock to four new employees. The grants were offered as material inducement to the employees' employment with Amwell. globenewswire.com - 2 months ago
Amwell® to participate in upcoming investor conference BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor conference. Ido Schoenberg, M.D. globenewswire.com - 2 months ago
American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript American Well Corporation (NYSE:AMWL ) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Stan Berenshteyn - Wells Fargo Securities Jailendra Singh - Truist Securities Eric Percher - Nephron Research Charles Rhyee - TD Cowen Matt Shea - Needham & Company Kevin Caliendo - UBS David Larsen - BTIG Jessica Tassan - Piper Sandler Operator Thank you for standing by and welcome to Amwell's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 2 months ago
Compared to Estimates, American Well (AMWL) Q4 Earnings: A Look at Key Metrics Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 months ago
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates American Well Corporation (AMWL) came out with a quarterly loss of $2.77 per share versus the Zacks Consensus Estimate of a loss of $2.82. This compares to loss of $3.40 per share a year ago. zacks.com - 2 months ago
Amwell® Announces Results for Fourth Quarter and Full Year 2024 BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report. globenewswire.com - 2 months ago
American Well (AMWL) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates Get a deeper insight into the potential performance of American Well (AMWL) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com - 2 months ago
Amwell® to report fourth quarter and full year 2024 operating results BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12. globenewswire.com - 3 months ago
8. Profile Summary

American Well Corporation AMWL

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 109 M
Dividend Yield 0.00%
Description American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Contact 75 State Street, Boston, MA, 02109 https://amwell.com
IPO Date Sept. 17, 2020
Employees 877
Officers Dr. Ido Schoenberg M.D. Chairman & Chief Executive Officer Ms. Amber Howe Chief People Officer Dr. Cynthia Horner FAAFP, M.D. Chief Medical Officer & President of Amwell Medical Group Ms. Phyllis I. Gotlib President of Amwell International Mr. Dan Zamansky Chief Product & Technology Officer Mr. Mark J. Hirschhorn CPA Chief Operating Officer & Chief Financial Officer Mr. Paul Francis McNeice Vice President of Accounting Ms. Sue Dooley Head of Investor Relations Dr. Roy Schoenberg M.D., M.P.H. Executive Vice Chairman